Please login to the form below
tasimelteon
This page shows the latest tasimelteon news and features for those working in and with pharma, biotech and healthcare.
BMS' Opdivo backed as melanoma therapy in EU
Vanda Pharmaceuticals got the go-ahead for Hetlioz (tasimelteon) for the treatment of non-24-hour sleep wake disorder in totally blind adults - which was approved in the US last year -
Latest news
-
FDA approves sleep disorder drug for blind people
Vanda Pharmaceuticals is now allowed to market its drug Hetlioz (tasimelteon) to treat a condition called non-24-hour sleep-wake disorder, which causes problems in the sleep cycle of blind
-
FDA panel backs sleep pattern drug for blind
A Food Drug and Administration (FDA) advisory committee voted unanimously to recommend approval of Vanda Pharmaceuticals' Hetlioz (tasimelteon) for non-24-hour disorder (N24) in the totally blind. ... Tasimelteon acts on melatonin MT1/MT2 receptors and
More from news
Approximately 2 fully matching, plus 1 partially matching documents found.
Featured jobs
- Scientific Director - Medical Education - Cheshire & London ...
-
Excellent Remuneration Package
- Senior Medical Writer– Medical Education – Oxford - London
-
Excellent Remuneration Package
- Senior Medical Writer – Leading Medical Communications Agency – ...
-
Highly Competitive Remuneration Package
- Graduate / Entry Level Opportunities – Medical Communications – ...
-
Highly Competitive Remuneration Package
-
Account Director, Medical Education
-
Salary TBC
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
- Experienced / Senior Medical Writer - MedComms - Cardiff - Wales
-
Excellent Salary and Benefits on offer
-
Senior Medical Writer
-
Salary TBC
- Scientific Director - Medical Communications Agency - New York
-
Excellent Remuneration Package
- Senior / Principal Medical Writer – Medical Education - UK &...
-
Excellent Salary and Benefits on offer
Subscribe to our email news alerts
- Key success factor (KSF)
- Genital herpes vaccine candidate heads for human studies
- Biogen defends aducanumab filing plan amid scepticism
- UPDATED: BMS completes Celgene merger after FTC okay
- Novartis strengthens case for its combination asthma drug
- Senate panel confirms Stephen Hahn as next FDA commissioner
- AstraZeneca’s Calquence impresses in previously untreated CLL
- Armed with new data, BMS plans filings for Celgene CAR-T liso-cel
- Bluebird bio’s sickle cell gene therapy shows early-study benefit
- Sangamo steps up BioMarin chase with haemophilia gene therapy data
- The 2019 CPhI Pharma Index Report
- Five key trends in precision and personalised healthcare
PMHub
Valid Insight
Valid Insight is an award-winning pharmaceutical global market access consultancy....
Latest intelligence
- The 2019 CPhI Pharma Index Report
- Examining this year’s industry performance...
- Five key trends in precision and personalised healthcare
- Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
- OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
- Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...
Quick links
Infographics
